Objective: Concerns about the radiation dose associated with CT scanning have led to a call for establishment of diagnostic reference levels. Self-complete surveys have been used extensively to gather this information however, departmental Radiological Information System's/Picture Archive Communication System's (RIS/PACS) also hold this information. We compared dosimetry derived from survey with that using RIS/PACS's.
Introduction
CT scanning has always been recognised as a relatively high radiation dose procedure, but in the early days there was no viable alternative. No other modality could compete with CT on the diagnostic accuracy of brain scans; and when CT of the rest of the body first began, its use was largely limited to cancer patients where radiation dose was less of a concern given the balance of risks [1] . Today, CT is used extensively in benign disease and young patients, for whom radiation protection considerations hold greater weight [1, 2] .
Awareness and concern regarding the high burden of radiation dose to the population stemming from CT began in the late 1980s following a survey conducted by the UK National Radiological Protection Board [3] .
It found, despite comprising only 2% of all medical imaging examinations, CT contributed a disproportionately large proportion (20%) of the collective population dose from diagnostic imaging [3, 4] .
The survey also found radiation doses from CT were trending in a direction at odds with the decreasing collective patient doses received from conventional x-ray examinations [3] . Rather, CT examinations had grown steadily to become a significant source of population exposure from medical radiology [4] . A followup study showed CT in the UK had doubled both its contribution to the population effective dose (40%) and the proportion of all radiological examinations (4%) by 1995 [5] . Similar findings were reported in other developed countries such as Switzerland, [6] Germany, [7] the Netherlands [8] and the US [9] . Mettler et al [9] found CT in the USA accounted for 11% of diagnostic radiological procedures in 1999, compared with only 6% in 1990. This study also showed CT accounted for 67% of the total effective radiation dose from diagnostic imaging in 1999 [9] . Of particular concern, Mettler et al [9] found 11% of CT examinations were performed on children. In 1998, the Royal College of Radiologists (UK) estimated CT contributed approximately one half of the collective dose from all examinations, with the average in UK CT workload to be a 24% increase per year against only 2% for all other medical and dental radiological procedures [10] .
Concerns have been expressed about the radiation dose associated with CT scanning, which have led to guidelines, advising on clinical indications for utilisation or diagnostic reference levels (DRL's) for the radiation dose received from each type of examination [1, 5, 11] . Due to paucity of data, estimates of radiation dose and cancer risk from CT scanning to underpin the creation of DRL's have been undertaken using self-report surveys combined with 'typical' CT protocol / machine settings [12] [13] [14] . However, this data capture technique has inherent limitations typical of all self-complete surveys such as response bias, low response fraction, poor generalizability (due to the data captured not being a representative sample either purposefully or otherwise) and, if the instrument has not been appropriately validated, poor validity and reliability.
Databases of CT scanner radiation dose facilitated by Radiological Information Systems (RIS) and Picture
Archiving Communication Systems (PACS) could enable comprehensive routine institutional benchmarking, optimisation of CT protocols and quality control [15] . These databases would also enable more accurate patient specific dose estimation than possible from data sources available previously, which would ultimately lead to more accurate patient specific risk assessment to better inform imaging decisions [15, 16] . However, while the data required are captured in individual department RIS/PACS, extracting these data efficiently remains problematic. Thus self-report survey methods are currently used extensively for capture of national and regional CT dose information.
The aim of this study was to compare the concordance (reliability and validity) of the radiation dose derived from a recognised international self-complete survey data capture instrument with dose obtained from data extracted from RIS/PACS (i.e. the gold standard) for a range of CT scanning examination types undertaken in the same public hospital.
Materials and Methods
Technical data on local CT practice were collected from a large metropolitan tertiary (teaching) hospital in Western Australia using (i) a self-complete survey and (ii) information contained in the dose report obtained from the PACS database for diagnostic CT scanning examinations performed on adults using the same make and model 64 slice scanner in the following six clinical scenarios.
1.
Routine Committee, which exempted the study from requiring individual patient consent.
Data collection: Survey data
Technical data were collected by means of a questionnaire completed by the chief CT radiographer in early 2011. The questionnaire was identical to the survey used by the national survey of doses from CT in the UK in 2003 [12] , amended only in terms of the clinical scenarios examined (addition of 'chest' for pulmonary embolus and removal of 'abdomen' for liver metastases) and limited to examinations performed on adults.
The questionnaire sought technical data in relation to examinations performed on 'average-sized' patients to represent 'usual practice'. Technical information was collected for each clinical scenario (excluding the scout view) consisting of separate scanning sequences (phases) where appropriate, each representing a single helical exposure or a series of similar axial exposures using identical scan conditions. The data included various technical parameters such as kilovoltage (kV), milliamperage (mA), tube rotation times, collimation widths, pitch, scanning method and typical anatomical reference start-stop positions of the scan.
Respondents were asked to report the average volume weighted CT dose index (CTDIvol) and dose-length product (DLP) based on up to ten standard ('average-sized') adult patients undergoing each examination type, as performed by the 2003 UK dose survey [12] . 
Radiation dosimetry
For both sets of data (survey and PACS), dosimetry involved reporting of CTDIvol, DLP values and calculation of organ and effective dose for each sequence using scan settings provided by the data. Scannerspecific dosimetrics published by ImPACT are included within the CT patient dosimetry calculator [17] . For sequences performed with automatic tube current modulation, doses were calculated using reported values, where available, of (average) tube current or current-time product (mAs) including the effects of modulation. For survey data the reported anatomical start-stop locations were used to determine the placement of the scanning field on the ImPACT dosimetry calculator. However, for the PACS data the average scan length of the cases collected, obtained by dividing DLP by CTDIvol, was used to modify the 
Analysis of inter-rater agreement
Evaluations of the agreement of organ dose and effective dose derived using PACS versus self-reported survey data were conducted under three scenarios: (i) the radiation doses calculatedd from PACS and survey data both adjusted to one decimal place; (ii) where the two values differed by <= 1 the PACS value was reset to be equal to survey values; and (iii) where the two values differed by <=5 the PACS value was reset to be equal to survey values.
The reliability (inter-rater agreement) of the two data collection instruments as input to radiation dosimetry calculations was assessed using the intraclass correlation coefficient (ICC) separately for each clinical scenario. We used the ICC in two distinct ways. The first ICC evaluated the absolute agreement of the organ and effective doses produced for single measures, this is the reliability of the ratings for one, typical, single dose [18, 19] . The second ICC used was with respect to average measures, the reliability of all the organ and effective dose produced by the different data collection instruments averaged together [18, 19] . In addition, the concordance correlation coefficient (ρc) was used to determine the degree to which pairs of organ / effective doses resulting from the two data collection instruments related to a line of best fit (set to 45° through the origin) [20] . The data were evaluated for both precision (how far each observation deviated from the best-fit line) and accuracy (how far the best-fit line deviated from the 45° line through the origin).
The values of the concordance correlation coefficient were interpreted using a descriptive scale suggested by The equality of measurements (ie radiation doses) from two different analytical methods (PACS versus survey) was tested using Passing and Bablok regression. This is a linear regression procedure with no special assumptions regarding the distribution of the samples and the measurement errors [22] . This regression model was used to evaluate if the radiation doses calculated by the two methods differed by a constant amount (systematic differences) and for the presence of proportional differences in the values produced by the two methods.
Finally, Bland-Altman plots were used to graphically compare the radiation doses produced using data from the two data collection methods [23] . For this study the differences between the radiation doses produced by the two methods were plotted against the radiation doses produced by PACS data since this method is the reference or "gold standard" [24] .
Results
As shown in Table 1 the CT technical information for the six clinical scenarios investigated varied in terms of number of sequences, CTDIvol and DLP across the data collection methods. Data on actual examinations undertaken, sourced from the PACS, showed that all scenarios except 'head' and 'abdomen/pelvis' had a median number of sequences greater than one. Only a single sequence was reported on the self-complete survey for all scenarios. Comparison of CTDIvol showed the average across the cases collected using PACS data was substantially lower than self-reported in three scenarios. The greatest difference occurred in 'chest'
for chronic obstructive pulmonary disease with a CTDIvol reported nearly three times larger than the PACS mean CTDIvol. The DLP was consistently lower using the average of the PACS data compared with selfreport. Table 2 presents the organ and effective radiation dose computed using the two methods of data collection.
The PACS data produced substantially lower (> 2mSv) effective doses in three scenarios ('chest' for pulmonary embolism, chronic obstructive pulmonary disorder and 'abdomen/pelvis'). Conversely, the PACS data produced substantially higher (>2mSv) effective doses in two scenarios ('chest' for lung cancer and 'chest/abdo/pelvis').
The individual organ doses did not follow the pattern described for the whole body effective dose. PACS data produced higher doses in organs near the limits of the scanning field, because the scan lengths observed in the PACS data were substantially longer than those calculated using the self-reported anatomical start-stop reference points. For example, in the 'chest' for lung cancer and pulmonary embolism scenarios the radiation dose to the thyroid was higher using the PACS data by 38.9 and 29.7mGy respectively. Table 3 presents the analysis of agreement between the two data capture methods. There was moderate agreement, according to the ICC and concordance (pc) for some scenarios, such as 'head', 'abdo/pelvis' and 'chest/abdo/pelvis.' In all three of these scenarios the precision (p) was high (>=0.98), but the accuracy (C b )
was only moderate. Both the ICC and concordance were poor in the remaining three scenarios. Particularly poor agreement was observed on the 'chest' for chronic obstructive pulmonary disorder scenario, where the ICC and pc were <0.6. While the precision in this scenario was perfect (1.00), the accuracy was only 0.56, indicating that the pairs of organ doses produced by the two methods were strongly linearly related, but departed substantially from the 45degree line of concordance.
Differences in the typology of the agreement was reflected in the regression analysis (Table 4) , which evaluated the degree of systematic and proportional difference observed in the dosimetry produced using the two data capture methods. In the 'chest' for chronic obstructive pulmonary disorder scenario, there were only non-significant minor systematic differences between the two methods (A = 0.00 [-0.10 to 0.056]).
There were significant proportional differences (B = 2.64 and the 95% confidence interval did not include 1), indicating a non-constant significant difference in the organ dose produced. In contrast, there were no systematic differences and only non-significant proportional differences in the 'head' scenario, indicating the dosimetry produced by the two data capture methods were in good agreement.
When all the scenarios were evaluated together (either using effective dose or organ dose) the agreement was poorer than when evaluated individually. This is shown in both tables 3 and 4, but is most apparent in Figure   1 . Panel A of Figure 1 shows the Bland-Altman plot for effective dose comparing the differences between the two data capture methods with the dosimetry produced using PACS (ie, the reference or gold-standard method). In Figure 1 
Discussion
The results of our study show radiation dosimetry calculations differed, both systematically and proportionally, when using self-report survey data and PACS data sources. Importantly, the study found the differences were not consistent across CT examination types, indicating the disparity cannot be adjusted using a simple correction factor. The disparity was greater and more variable for organ dose than effective dose, most likely resulting from the reliance of the survey data on 'standardised' anatomical start and stop limits compared with actual start and stop limits in the PACS data. The PACS data also provided information regarding the variance of the radiation dose unavailable using the survey instrument, because the survey instrument required the respondent to provide a single CTDIvol and DLP measure averaged from 10 'average' adult patients, whereas the PACS data provided individual level data for each randomly selected case.
The observed discordance between the organ dose calculated from each data source is an important finding since individual or population risk estimates are derived using organ doses rather than effective dose [25] .
Controversies persist about the effect of low-level radiation exposure and how these risks should be reported, especially to the public ; however it is generally accepted there is no safe level of exposure (ie, the linear-nothreshold model) [25] . In light of concerns regarding the increasing use of CT scanning and the expansion of its use in high risk populations such as children, several studies have attempted to quantify the risk to the population of CT scanning based upon radiation doses generated from surveys [13, 26] . In light of our results demonstrating the discordance of the data collected using self-complete surveys with a more rigorous data source, care should be taken when interpreting the results of these studies.
In contrast, guidance regarding the establishment of DRLs recommend they be based on the 75 th percentile of the radiation dose measured across providers' derived dose data from a minimum of 10 standard sized patients undergoing standard examinations [27] . Historically DRLs have been articulated in terms of both the effective dose and the DLP. DLPs have to date been generated exclusively from self-complete surveys [12, 28, 29] and, while our study has shown the data are not concordant with data obtained from PACS, the bias with respect to effective dose does appear to follow a more consistent pattern allowing the potential for correction to be applied.
Strengths and Limitations
This study used a survey instrument applied extensively in the United Kingdom for collection of the selfreport data [12] , without modification (except in terms of the clinical; scenarios examined) and is also recommended by the European Commission on Radiation Protection [30] . It represents a widely accepted example of this data collection method. Data from the PACS were extracted manually from the same institution and over the same time period as the survey. In addition, all CT examinations included in the study were undertaken on the same make and model of CT scanner and by the same technical staff. Data extracted from PACS were a random sample of 20 examinations on adult patients (ie double the number recommended for generation of DRLS [27] ) and were limited to examinations most closely matched the clinical scenarios on the survey after consultation with CT technical and clinical staff. The survey was completed by a senior radiographer who specialised in CT prior to collection of the PACS data, and the same individual was consulted regarding matching of PACS examination codes to the clinical scenarios used in the survey.
Since the study was conducted at a single hospital site, the results may not represent concordance between the two data collection methodologies in different sites; thus it is unknown if the disparities observed would have been larger or smaller if multiple providers were included in the study. The study was also restricted in the number of CT examinations evaluated; however, a range of examination methodology and anatomical locations were included. This study was limited to an evaluation of reliability and assumed PACS data as the gold standard. Reliability is only one of the potential limitations to self-complete survey data collection instruments and issues such as response bias and response fraction were not evaluated. In our study, due to the manual nature of the PACS data extraction, we required the provider to agree to participate in the study and hence there would have been no benefit in terms of response fraction. However, if the recommendation of the European Commission on Radiation Protection [30] is realised (ie that national authorities responsible for population dose surveys gather electronic information on patient doses from RIS/PACS into national databases established for the development and monitoring of DRLs and population dose estimates) then this data collection method would be far superior in terms of both response fraction and response bias. Our study did not evaluate the cost differences between the two methodologies; however, since collection of PACS data for our study was done manually (because data were not able to be extracted automatically), the PACS data collection was significantly more expensive to undertake compared with the survey. This additional cost needs to be considered when evaluating the relative advantages and disadvantages of the two data collection methods. Should national or even local databases become established, then the cost of such data would be significantly reduced. Implementing dose databases for DRL and audit purposes can maintain the anonymity of patients by only collating or aggregating the data required for dose calculation. Such a system would be complicit with Australian health data and biospecimen law [31] , ensuring no breach of legal obligations is made and the ethical calculus strongly favours the public interest in radiation protection and avoidance of unnecessary harm to patients. Data from both the survey and PACS data were analysed in an identical manner to produce organ and effective doses and this method has been used previously and is well established. Analysis of the dosimetry data for reliability was undertaken using the most appropriate advanced statistical methods and provided a range of indicators of concordance.
Conclusion
Due to increasing concerns about the radiation dose from CT scanning examinations, robust methods for collection of CT dose data are required. Currently self-report surveys are used extensively for this purpose but suffer from limitations. The increasing availability of electronic databases to capture information required for the evaluation and monitoring of CT radiation dose provides an opportunity for better quality data in a cost-effective manner, eliminating many of the potential biases. This study has confirmed data extracted from RIS/PACS is superior to self-reported survey data and has shown survey data contains both proportional and systematic bias not consistent across CT examinations. We recommend national and local databases are established to routinely capture aggregated and anonymous CT dose data for the development and monitoring of DRLs and surveillance of population radiation dose. * Seq = Self-reported number of sequences (phases) usually undertaken for the examination. † kV= Self-reported kilovoltage usually used or the examination. ‡ Self-reported pitch (mm) usually used for the examination. § CTDIvol = Self-reported average Volumetric CT Dose Index, measured in mGy for the examination. Median kilovoltage observed across the cases collected. † † Median pitch (mm) observed across the cases collected. ‡ ‡ Mean (standard deviation) of the Volumetric CT Dose Index (mGy) observed for the cases collected. Note where multiple sequences (phases) were observed the CTDIvol for the examination was the sum of the sequence specific CTDIvol. § § Mean (standard deviation) of the Dose Length Product (mGy.cm) observed for the cases collected. Note where multiple sequences (phases) were observed the DLP for the examination was the sum of the sequence specific DLP.
||||
Only 10 cases were identified over the data capture time frame.
Both data collections were based on examinations performed on the same model and make of CT scanner. Table 2 Organ radiation dose (mGy) and whole body effective radiation dose (mSv) of CT scanning protocols obtained using self-complete survey and data extracted from departmental picture archival communication system as input to radiation dosimetry calculations Organ and effective radiation dose calculated using the self-reported (survey) dose information. † Mean of the organ and effective radiation dose effective doses calculated across the cases using case specific scanning and dose information. ‡ Difference in radiation dose calculated using picture archival communication system (PACS) data compared with that calculated using self-report data. A negative number indicates radiation dose is lower using PACS data. § Organ dose reported in mGy -the amount of radiation received by the organ specified not modified by the tissue weighting factor for the organ.
||
Effective dose reported in mSv -The whole body effective dose is the sum of the modified (using ICRP 103 tissue weighting factor for each organ) organ dose. This is a measure of the cancer risk to the individual due to ionizing radiation taking into account both the type of radiation and the radio-sensitivity of each organ being irradiated. Note anatomical start and stop positions used during calculation of the radiation dose for survey data were those reported on the survey. For the PACS data CT staff were interviewed and the reported anatomical start stop locations modified to match the average scan lengths for cases collected for each protocol. The intra class correlation coefficient measures the degree of absolute agreement among the radiation dose estimated using the two measurement instruments providing input data to the radiation dose calculation (PACS vs Survey). † Estimates the reliability of single measurements. ‡ Estimates the reliability of the averages of all measurements. ρc is the concordance correlation coefficient. It evaluates the degree to which pairs of observations (ie radiation dose calculated using PACS and survey data) fall on the 45° line (ie line of absolute agreement) through the origin. ρ is the Pearson correlation coefficient, which measures how far each observation deviates from the best-fit line, and is a measure of precision. Cb is a bias correction factor that measures how far the best-fit line deviates from the 45° line through the origin, and is a measure of accuracy. Passing & Bablok (1983) [23] .
*A Systematic differences. The intercept A is a measure of the systematic differences between the two methods. The 95% confidence interval for the intercept A tests the hypothesis that A=0. This hypothesis is accepted if the confidence interval for A contains the value 0. If the hypothesis is rejected, then it is concluded that A is significantly different from 0 and the methods differ by a constant amount. †B Proportional differences. The slope B is a measure of the proportional differences between the two methods. The 95% confidence interval for the slope B tests the hypothesis that B=1. This hypothesis is accepted if the confidence interval for B contains the value 1. If the hypothesis is rejected, then it is concluded that B is significantly different from 1 and there is a proportional difference between the two methods. ‡RSD Random differences. The residual standard deviation (RSD) is a measure of the random differences between the two methods. 95% of random differences are expected to lie in the interval -1.96 RSD to +1.96 RSD. If this interval is large, the two methods may not be comparable.
Linear model validity: the Cusum test for linearity is used to evaluate how well a linear model fits the data. § Indicates significant deviation from linearity (ie p value <0.05).
